Keith Goldstein - Jul 31, 2023 Form 4 Insider Report for VerifyMe, Inc. (VRME)

Signature
/s/ Margaret Gezerlis, Attorney-in-Fact for Keith Goldstein
Stock symbol
VRME
Transactions as of
Jul 31, 2023
Transactions value $
$0
Form type
4
Date filed
7/31/2023, 04:29 PM
Previous filing
Sep 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRME Common Stock, par value $0.001 per share 19.9K Jul 31, 2023 Direct
holding VRME Common Stock, par value $0.001 per share 5K Jul 31, 2023 By POC Advisory Group, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRME Restricted Stock Units Award $0 +80.8K $0.00 80.8K Jul 31, 2023 Common Stock, par value $0.001 per share 80.8K $0.00 Direct F2
holding VRME Stock Option (Right to Buy) 20K Jul 31, 2023 Common Stock, par value $0.001 per share 20K $9.75 By POC Advisory Group, LLC F3
holding VRME Stock Option (Right to Buy 20K Jul 31, 2023 Common Stock, par value $0.001 per share 20K $10.51 By POC Advisory Group, LLC F3
holding VRME Stock Option (Right to Buy) 40K Jul 31, 2023 Common Stock, par value $0.001 per share 40K $2.00 By POC Advisory Group, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Keith Goldstein is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Mr. Goldstein is a Managing Member of POC Advisory Group, LLC.
F2 These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the VerifyMe, Inc. 2020 Equity Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on 7/31/2026 in two equal tranches. Tranch 1 will vest on 7/31/2026 if the issuer's common stock during such period was at or above $2.75 for 20 consecutive trading days. Tranch 2 will vest on 7/31/2026 if the issuer's common stock during such period was at or above $3.75 for 20 consecutive trading days.
F3 This option is fully exercisable as of the date of this report.